SCHEMBL7744196

SCHEMBL7744196

CC(=O)Nc1oc(-c2ccc(-c3ccccc3)cc2O)nc1C1=CC=CCC1=S

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.54
FLT1 P17948 1/20 0.54
FLT4 P35916 1/20 0.54
KDM4E B2RXH2 3/20 0.38
APOBEC3A P31941 1/20 0.38
GFER P55789 1/20 0.38
HDAC1 Q13547 1/20 0.38
APOBEC3G Q9HC16 1/20 0.38
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ALDH1A1 P00352 2/20 0.36
POLB P06746 2/20 0.36
CASP3 P42574 1/20 0.36
SENP8 Q96LD8 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36
TSHR P16473 1/20 0.35
LMNA P02545 1/20 0.34
NR4A2 P43354 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7980768 0.93 KDR (0.45) KDRFLT1FLT4KDM4ENPC1
SCHEMBL7986670 0.91 KDR (0.50) KDRFLT1FLT4NPC1RAB9A
SCHEMBL7744779 0.91 KDR (0.43) KDRFLT1FLT4KDM4EHDAC1
SCHEMBL7744746 0.88 HPN (0.45) KDRFLT1FLT4SMN1; SMN2POLB
SCHEMBL7744056 0.87 HPGD (0.42) KDRFLT1FLT4KDM4EHDAC1
SCHEMBL7981618 0.87 KDR (0.44) KDRFLT1FLT4TSHRALOX15
SCHEMBL7979629 0.87 KDR (0.39) KDRFLT1FLT4KDM4EHDAC1
SCHEMBL7982878 0.85 MAPT (0.44) KDRFLT1FLT4KDM4ENPC1
SCHEMBL7987348 0.85 KDR (0.44) KDRFLT1FLT4KDM4ENPC1
SCHEMBL7979897 0.84 KDR (0.47) KDRFLT1FLT4KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed